Jacobs Levy Equity Management, Inc Procept Bio Robotics Corp Transaction History

Jacobs Levy Equity Management, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$26.7 - $37.02 $325,019 - $450,644	-12,173 Reduced 62.16%	7,409 $261,000
Q1 2023 May 15, 2023	SELL	$26.64 - $39.74 $253,746 - $378,523	-9,525 Reduced 32.72%	19,582 $556,000
Q4 2022 Feb 14, 2023	SELL	$38.78 - $46.78 $12,099 - $14,595	-312 Reduced 1.06%	29,107 $1.21 Million
Q3 2022 Nov 15, 2022	BUY	$30.9 - $50.65 $909,047 - $1.49 Million	29,419 New	29,419 $1.22 Million

266

38M

262K

257K

Ticker PRCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 44,592,300
Market Cap $4.17B
Description
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.